Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.
A Santa Maria man who was saved through a blood donation two years ago is returning the favor by donating blood himself as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback